Bacil Pharma Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 0.09 | 0.09 | 0.11 |
| Operating Expense | 0.06 | 0.02 | 0.07 |
| Net Profit | -0.01 | -0.02 | 0.62 |
| Net Profit Margin | -11.11% | -22.22% | 563.64% |
| Earning Per Share | 0.11 | 0.22 | 0.44 |
| EBIDTA | -0.01 | -0.02 | 0.62 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Sep 2026
Revenue0.09
Operating Expense0.06
Net Profit-0.01
Net Profit Margin-11.11
Earning Per Share0.11
EBIDTA-0.01
Effective Tax Rate0
